We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSTG:NYSEPure Storage, Inc. Analysis

Data as of 2026-05-22 - not real-time

$64.89

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Everpure Inc. trades around $65, sitting between its 20‑day SMA of 76.8 and 50‑day SMA of 68.9, indicating a neutral price stance despite a bearish MACD histogram (-0.48) and a “bearish” MACD signal line. The stock’s RSI of 57.7 suggests limited upward momentum, while volume is trending higher, adding short‑term pressure. Fundamentally, the company carries an extreme PE multiple of 123.3× versus an industry average of 39.5×, a PB ratio of 15.5×, and a debt‑to‑equity ratio of 127.4×, all of which point to severe overvaluation and leverage risk. Earnings growth is flat, operating margin is negative (-0.18), and free cash flow is modest at $376 M, reinforcing a value‑oriented rather than growth narrative. Recent analyst commentary lowered the price target to $80, well below the median analyst target of $90, underscoring a shift in sentiment amid high sector volatility (48.8 % 30‑day) and a max drawdown of -42 %. Overall, Everpure faces high systematic risk (beta ~2.27), a bearish technical outlook, and a weak profitability profile, suggesting caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • MACD histogram negative indicating bearish momentum
  • RSI near 58 limiting immediate upside
  • Volume trend increasing but price remains between SMA20 and SMA50

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Trailing PE of 123.3× far above industry norm
  • Debt‑to‑equity ratio of 127.4× creates solvency concerns
  • Operating margin of -0.18 signals ongoing profitability issues

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Zero revenue growth eliminates growth premium
  • Forward PE of 23.9× remains elevated relative to earnings outlook
  • JPMorgan price‑target cut to $80 reduces valuation ceiling
  • AI‑driven sector demand likely to favor better‑balanced peers

Key Metrics & Analysis

Financial Health

Profit Margin5.14%
P/E Ratio123.3
ROE13.68%
ROA1.66%
Debt/Equity127.36
P/B Ratio15.5
Op. Cash Flow$880.1M
Free Cash Flow$376.7M
Industry P/E39.5

Technical Analysis

TrendNeutral
RSI57.7
Support$69.08
Resistance$93.92
MA 20$76.79
MA 50$68.85
MA 200$74.41
MACDBearish
VolumeIncreasing
Fear & Greed Index91.3

Valuation

Target Price$89.89
GradeOvervalued
TypeValue

Risk Assessment

Beta2.27
Volatility48.80%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.